Hazardous Substances (Hazard Classification) Notice 2020
Hazardous Substances (Hazard Classification) Notice 2020 | October 2020 3 Hazardous Substances (Hazard Classification) Notice 2020 This notice is issued by the Environmental Protection Authority (the Authority) under section 74 of the Hazardous Substances and New Organisms Act 1996 (the Act).It is issued in accordance with
Link to this page:
Documents from same domain
Hazardous Substances (Hazardous Property Controls) Notice 2017 | EPA Consolidation 10 application plot means the part of the application area where the substance is, or is intended to be, directly applied approved filler has the same meaning as in the HSW HS Regulations Authority means the Environmental Protection Authority
Substances and articles that have a fire hazard and either a minor blast hazard or minor projection hazard, or both, but not a mass explosion hazard 1.4B, 1.4C, 1.4D, 1.4E, 1.4F, 1.4G, 1.4S Substances and articles that present no significant explosive hazard or that present only a small hazard in the event of ignition or initiation 1.5 D
hazard statement means a statement assigned in the GHS to a hazard class and category describing the nature of the hazards of a hazardous substance including, if appropriate, the ... or in a safety data sheet to indicate to the reader the relative severity level of a hazard, and to alert the reader to a potential hazard ... emergency event; or ...
(b) a list of the ingredients in the product (except colour additives) in concentrations of less than 1% in any order; and (c) colour additives in any order; and (d) flavour or flavours, which must be described in the list of ingredients by: (i) the words, “flavour” or “flavours” or …
ā Te Mana Rauhī Taiao whakatau i te hononga ake, i te hononga motuhake a Ngāi Māori ki te taiao The unique relationship of Māori to the environment informs EPA decision making The wawata reflects our commitment to respecting Te Tiriti o Waitangi, taking into account tikanga (customs) and kawa (protocol).
Commencement This consolidated notice is effective as at 30 April 2021. 3. Application This notice applies to manufacturers, importers, and suppliers of hazardous substances. This notice does not apply in relation to— (a) substances required for the motive power or control of a vehicle, aircraft, or ship, that are
Others pointed out that any chemical is dangerous if used incorrectly, ... the most common herbicides used in Aotearoa New Zealand, and around the world. It was first approved for use in Aotearoa New Zealand in the 1970s. Glyphosate products are sold under a variety of brand names, with Roundup being the most recognisable brand. ...
Carcinogenicity studies may be recommended for some pharmaceuticals if there is concern about their carcinogenic potential. Criteria for defining these cases should be very carefully considered because this is the most important reason to conduct carcinogenicity studies for most categories of pharmaceuticals. Several factors which
61 carcinogenicity potential, the approach described in S1B of conducting a 2-year rat 62 carcinogenicity study together with a carcinogenicity assessment in mice (short term or 2-year 63 study) remains the most appropriate strategy. 64 2.1 Factors to consider for a …
Carcinogenicity Teratogenicity or other developmental toxicity† Reproductive toxicity† *ASHP  definition of hazardous drugs 1. Genotoxicity (i.e., mutagenicity and clastogenicity in short-term test systems) 2. Carcinogenicity in animal models, in the patient population, or both, as reported by the Interna-
potential carcinogenicity hazard for that chemical. This date provides a key as to which set of cancer guidelines were used in the review. Note that the classification of potential carcinogenicity generally is not reevaluated unless new data are submitted.
CARCINOGENICITY TESTING 27 EVERY STEP OF THE WAY The objectives of carcinogenicity studies • Identification of carcinogenic properties of a test item • Identification of target organs • Characterisation of dose response relationship • Identification of NOEL or NOAEL
programme is to elaborate and publish in the form of monographs critical reviews of data on carcinogenicity for agents to which humans are known to be exposed and on specific exposure situations; to evaluate these data in terms of human risk
11 countries met at IARC 3–10 March 20on15 to assess the carcinogenicity of tetrachlorvinphos, parathion, malathion, diazinon and glyphosate. The in, -person meeting followed nearly a year of review and preparation by the IARC secretariat and the Working Group, including a comprehensive review of the latest available scientific evidence.
a DNA reactive mechanism of carcinogenicity and therefore are not in scope of the ICH M7 guidance (e.g., acetamide and hydroxylamine). M7 Q&As 5 3.2 Should mutagenic, non-carcinogenic impurities be controlled according to ICH M7? No. Mutagens that are demonstrated to be non-carcinogenic in appropriate and well- ...
The Development Safety Update Report (DSUR) proposed in this guideline is intended to be a common standard for periodic reporting on drugs under development (including marketed drugs that …